Organigram Global Announces CEO Succession Plan
Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization's growth and transformation from a cannabis company with $80M in net revenue to becoming the market share leader in Canada with over $250M in net revenue. Under her leadership, the Company completed an expansion of its facility in Moncton, New Brunswick, doubling cultivation capacity, as well as three strategic acquisitions that led to the Company's #1 share positions in vapes, hash and pre-rolls in Canada. In addition, Ms. Goldenberg oversaw Organigram's international expansion with export sales into Germany, UK and Australia. The latest acquisition of Collective Project, announced on April 1, 2025, signaled the first revenue recognized by Organigram from the U.S. market.
This announcement follows the Company's second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram's financial performance. This includes realizing a 74% increase in net revenue year-over-year and delivering improvement across key financial metrics.
'After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next chapter,' said Ms. Goldenberg. 'Reflecting on my journey, I am extremely proud of what has been accomplished in this nascent industry. The challenges we faced and the successes we achieved underscore the immense potential that still lies ahead for the cannabis industry.'
'On behalf of the Board, I express our gratitude to Beena for her exceptional leadership and commitment to Organigram. Beena has been instrumental in positioning Organigram as a market leader in Canada and poised for global expansion,' said Peter Amirault, Chairman of the Board, Organigram. 'She has created an excellent base for both domestic and international growth for Organigram. And therefore, the Company is well positioned to take advantage of this significant opportunity. The Board remains confident in the Company's strategic direction as well as its leadership team, and we are committed to appointing a new CEO who will continue to drive our vision forward, ensuring that the Company remains at the forefront of cannabis innovation and growth.'
The Board is in the process of initiating a comprehensive CEO selection process focused on identifying a candidate with the right mix of skills and experience to lead the Company in its next chapter of growth.
'It has been an honour to lead Organigram Global through this critical chapter in our evolution, and I am grateful to have had the privilege of working with so many talented and passionate people who have played a significant role in our collective growth and achievements,' said Ms. Goldenberg. 'Over the next four months I will remain focused on driving Organigram growth and profitability while supporting the smooth onboarding of a new CEO to lead the Company forward in its next phase of growth.'
About Organigram
Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets.
Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences, future prospects and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov).
Examples of forward-looking statements in this news release include, among others, statements regarding the Board's intended CEO selection process, Organigram's strategic direction and Ms. Goldenberg's planned focus until her retirement date. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all.
The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
American Airlines Group Inc. (AAL) Reports Second-Quarter Results; Exceeds Expectations
American Airlines Group Inc. (NASDAQ:AAL) is included in our list of the . Pixabay/Public Domain On July 24, 2025, American Airlines Group Inc. (NASDAQ:AAL) reported Q2 2025 earnings. The stronger-than-expected earnings were marked by adjusted EPS of $0.95, exceeding the consensus estimate of $0.79. Furthermore, resilient premium demand and strong international performance, particularly in transatlantic routes, helped the company post revenue of $14.4 billion. However, domestic unit revenue dropped 6% YoY due to softness in domestic leisure. Meanwhile, American Airlines Group Inc. (NASDAQ:AAL) maintained an operating margin of 8% and generated $791 million in free cash flow during the quarter. The company's financial health further improved with debt repayments, taking its net debt to $29 billion, the lowest since 2015. For Q3, American Airlines Group Inc. (NASDAQ:AAL) has projected EPS to range between a $0.10 and $0.60 loss. The company does consider July as the trough, but anticipates sequential improvement in revenue. For the full year, it expects its EPS to range from a $0.20 loss to a $0.80 profit. Looking beyond 2025, American Airlines Group Inc. (NASDAQ:AAL) expects a full recovery of indirect channel share by the end of this year which would boost 2026 revenue. On the analyst front, BofA, on July 25, 2025, increased its price target on American Airlines Group Inc. (NASDAQ:AAL) from $12 to $13, maintaining a 'Neutral' rating. The analyst cited Q3 guidance that fell below expectations. American Airlines Group Inc. (NASDAQ:AAL), a network air carrier, provides scheduled air transportation services for passengers and cargo. It is included in our list of cheap travel stocks. While we acknowledge the potential of AAL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Most Undervalued Cloud Stocks Under $10 According to Hedge Funds and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Indivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq
We recently compiled a list of Indivior PLC stands seventh on our list among the best mid cap stocks according to billionaires. Indivior PLC (NASDAQ:INDV) is a pharmaceutical company focused on opioid addiction treatment, particularly through its flagship product SUBLOCADE, a monthly buprenorphine injection. The company has demonstrated strong growth and resilience, recently reaching a 52-week stock high. In 2025, Indivior PLC (NASDAQ:INDV) underwent a strategic leadership overhaul to strengthen its market position in the U.S., the primary arena for its operations. Joe Ciaffoni took over as CEO, bringing a fresh vision to the company, while Patrick Barry joined as Chief Commercial Officer to drive commercial expansion, especially around SUBLOCADE. Tony Kingsley also joined the board to enhance governance. These changes reflect a focused effort to boost performance and align leadership with U.S. market priorities. In line with this strategy, the business announced its plan to shift its primary listing from the London Stock Exchange to Nasdaq, aiming for greater visibility and investor engagement in the American market. Photo by Matteo Badini on Unsplash On the clinical front, Indivior PLC (NASDAQ:INDV) presented new findings at the 2025 CPDD meeting showing that higher buprenorphine exposure may improve treatment outcomes in patients with high fentanyl use, a critical step given the ongoing fentanyl crisis. The FDA also approved updated labeling for SUBLOCADE, further expanding its clinical utility. While we acknowledge the potential of INDV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Hamilton Spectator
36 minutes ago
- Hamilton Spectator
Mullen Automotive Inc. Changes Name to Bollinger Innovations, Inc. Effective Today
BREA, Calif., July 28, 2025 (GLOBE NEWSWIRE) — via IBN – Bollinger Innovations, Inc. (Nasdaq: BINI) ('Bollinger Innovations' or the 'Company'), an electric vehicle ('EV') manufacturer, today announces that the Company's previously announced name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective July 28, 2025. The Company's Nasdaq stock symbol change to BINI is effective as of the market open on the same date. The CUSIP number for the Company's common stock is not affected by the name or stock symbol change. The Company's name and stock symbol change has no affect on the Company's legal structure or business operations. Stockholders are not required to take any actions in connection with these changes. 'Our transition to Bollinger Innovation is complete and we now have commercial Class 1, 3 and 4 under one unified brand,' said David Michery, CEO and chairman of Bollinger Innovations, Inc. About Bollinger Innovations, Inc. Bollinger Innovations, Inc. (NASDAQ: BINI), effective July 28, 2025, and formerly, Mullen Automotive Inc. (Nasdaq: MULN), is a Southern California-based automotive company building the next generation of commercial electric vehicles ('EVs') with U.S. based vehicle manufacturing located in Tunica, Mississippi. As of January 2024, both the ONE, a Class 1 EV cargo van, and THREE, a Class 3 EV cab chassis truck, are California Air Resource Board ('CARB') and EPA certified and available for sale in the U.S. The Company's commercial dealer network consists of seven dealers, which includes Papé Kenworth, Pritchard EV, National Auto Fleet Group, Ziegler Truck Group, Range Truck Group, Eco Auto, and Randy Marion Auto Group, providing sales and service coverage in key West Coast, Midwest, Pacific Northwest, New England, and Mid-Atlantic markets. In September 2022, Bollinger Motors, of Oak Park, Michigan, became a majority-owned EV truck company of Bollinger Innovations. Bollinger Motors has passed numerous milestones including its B4, Class 4 electric truck production launch on Sept. 16, 2024, and the development of a world-class dealer network with over 50 locations across the United States for sales and service support. To learn more about the Company, visit . Forward-Looking Statements Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as 'continue,' 'will,' 'may,' 'could,' 'should,' 'expect,' 'expected,' 'plans,' 'intend,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'potential' and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Bollinger Innovations and are difficult to predict. Examples of such risks and uncertainties include but are not limited to Bollinger Innovations plan and timeframe related to changing its Company name and stock symbol. Additional examples of such risks and uncertainties include but are not limited to: (i) Bollinger Innovations ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Bollinger Innovations ability to maintain existing, and secure additional, contracts with manufacturers, parts and other service providers relating to its business; (iii) Bollinger Innovations ability to successfully expand in existing markets and enter new markets; (iv) Bollinger Innovations ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Bollinger Innovations business; (viii) changes in government licensing and regulation that may adversely affect Bollinger Innovations business; (ix) the risk that changes in consumer behavior could adversely affect Bollinger Innovations business; (x) Bollinger Innovations ability to protect its intellectual property; and (xi) local, industry and general business and economic conditions. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Bollinger Innovations with the Securities and Exchange Commission. Bollinger Innovations anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Bollinger Innovations assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Bollinger Innovations plans and expectations as of any subsequent date. Contact: Bollinger Innovations, Inc. +1 (714) 613-1900 Corporate Communications IBN Austin, Texas 512.354.7000 Office Editor@
